Complications |
|
|
|
|
|
|
Deaths |
|
|
5 |
-1.08 |
-2.59-0.43 |
0.16 |
Myocardial infarctions
|
|
|
5
|
0.28
|
-1.37-1.92
|
0.74
|
Recurrent strokes
|
|
|
5
|
0.26
|
-1.39-1.91
|
0.75
|
Hernia
|
|
|
5
|
-0.97
|
-2.02-0.07
|
0.07
|
Hemorrhage of the digestive tract
|
|
|
5
|
-0.72
|
-2.00-0.56
|
0.27
|
Hemorrhagic transformation at 24
hours
|
|
|
2
|
0.94
|
-0.20-2.08
|
0.11
|
Fever (>38 °C) |
|
|
4 |
-0.09 |
-0.89-0.71 |
0.82 |
Event |
|
|
|
|
|
|
All events |
|
|
|
|
|
|
At least 1 adverse event |
|
|
3 |
-0.12 |
-0.85-0.61 |
0.75 |
Any serious adverse event |
|
|
4 |
-0.06 |
-1.99-1.87 |
0.95 |
Frequent or special interest adverse events |
|
|
|
|
|
|
Lung infection |
|
|
5 |
0.06 |
-0.58-0.69 |
0.86 |
Urinary tract infection |
|
|
5 |
0.02 |
-0.95-0.99 |
0.97 |
Abnormal laboratory liver-function test |
|
|
3 |
-0.04 |
-2.26-2.18 |
0.97 |
Gastrointestinal disorders |
|
|
3 |
-0.04 |
-2.26-2.18 |
0.97 |
Herpes virus infection |
|
|
4 |
-0.03 |
-1.96-1.90 |
0.98 |
Arrhythmia |
|
|
3 |
0.67 |
-1.33-2.66 |
0.51 |
Macular edema |
|
|
3 |
-0.04 |
-2.26-2.18 |
0.97 |